These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 332345

  • 1. BCNU with and without cyclophosphamide, vincristine, and prednisone (COP) and cycle-active therapy in non-Hodgkin's lymphoma.
    Durant JR, Gams RA, Bartolucci AA, Dorfman RF.
    Cancer Treat Rep; 1977 Sep; 61(6):1085-96. PubMed ID: 332345
    [Abstract] [Full Text] [Related]

  • 2. Chemotherapy of non-Hodgkin's lymphomas: Eastern Cooperative Oncology Group experience.
    Bennett JM, Lenhard RE, Ezdinli E, Johnson GJ, Carbone PP, Pocock SJ.
    Cancer Treat Rep; 1977 Sep; 61(6):1079-83. PubMed ID: 71207
    [Abstract] [Full Text] [Related]

  • 3. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
    Hainsworth JD, Wolff SN, Stein RS, Greer JP, Cousar JB, Greco FA.
    Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
    [Abstract] [Full Text] [Related]

  • 4. 1,3-bis(2-chloroethyl)-1-nitrosourea(BCNU), cyclophosphamide, vincristine- and prednisone-(BCOP). A new therapeutic regimen for diffuse histiocytic lymphoma.
    Durant JR, Loeb V, Dorfman R, Chan YK.
    Cancer; 1975 Dec; 36(6):1936-44. PubMed ID: 1106833
    [Abstract] [Full Text] [Related]

  • 5. Non-cross-resistant combinations in stage IV non-Hodgkin's lymphomas.
    Bonadonna G, Monfardini S, Villa E.
    Cancer Treat Rep; 1977 Sep; 61(6):1117-23. PubMed ID: 71209
    [Abstract] [Full Text] [Related]

  • 6. [Cyclophosphamide-vincristine-prednisone combination in the treatment of lympho- and reticulosarcomas in adults (60 cases)].
    Gorin NC, David R, Stachowiak J, Najman A, Duhamel G.
    Nouv Presse Med; 1976 Nov 13; 5(38):2525-30. PubMed ID: 790316
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB.
    Cancer Chemother Pharmacol; 2002 May 13; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [Abstract] [Full Text] [Related]

  • 9. Overview of four clinical studies of chemotherapy for stage III and IV non-Hodgkin's lymphomas by the Cancer and Leukemia Group B.
    Nissen NI, Pajak T, Glidewell O, Blom H, Flaherty M, Hayes D, McIntyre R, Holland JF.
    Cancer Treat Rep; 1977 Sep 13; 61(6):1097-107. PubMed ID: 71208
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Combination chemotherapy in non-Hodgkin's lymphoma: results of long-term followup.
    Anderson T, Bender RA, Fisher RI, DeVita VT, Chabner BA, Berard CW, Norton L, Young RC.
    Cancer Treat Rep; 1977 Sep 13; 61(6):1057-66. PubMed ID: 71205
    [No Abstract] [Full Text] [Related]

  • 12. Results of combination chemotherapy of non-Hodgkin's lymphoma.
    Schein PS, Chabner BA, Canellos GP, Young RD, Berard C, DeVita VT.
    Br J Cancer Suppl; 1975 Mar 13; 2():465-73. PubMed ID: 1101932
    [Abstract] [Full Text] [Related]

  • 13. Randomized study comparing doxorubicin, cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (ACOMLA) with cyclophosphamide, doxorubicin, vincristine, prednisone, and bleomycin (CHOP-B) in the treatment of diffuse histiocytic lymphoma.
    Newcomer LN, Cadman EC, Nerenberg MI, Chen M, Bertino JR, Farber LR, Prosnitz LR.
    Cancer Treat Rep; 1982 Jun 13; 66(6):1279-84. PubMed ID: 6177407
    [Abstract] [Full Text] [Related]

  • 14. Non-Hodgkin's lymphomas-present status of chemotherapy.
    Young CW.
    Clin Bull; 1975 Jun 13; 5(1):20-3. PubMed ID: 776444
    [No Abstract] [Full Text] [Related]

  • 15. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
    Mihaljević B, Jancić-Nedeljkov R, Sretenović M, Milivojević G, Janković S, Petrović M.
    Srp Arh Celok Lek; 1998 Jun 13; 126(9-10):345-8. PubMed ID: 9863405
    [Abstract] [Full Text] [Related]

  • 16. European experience with ifosfamide in lymphomas.
    von Kalle AK, Schaadt M, Diehl V.
    Semin Oncol; 1989 Feb 13; 16(1 Suppl 3):73-7. PubMed ID: 2468184
    [Abstract] [Full Text] [Related]

  • 17. Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors.
    Bessell EM, Graus F, Lopez-Guillermo A, Lewis SA, Villa S, Verger E, Petit J.
    Int J Radiat Oncol Biol Phys; 2004 Jun 01; 59(2):501-8. PubMed ID: 15145169
    [Abstract] [Full Text] [Related]

  • 18. The COP-BLAM programs: evolving chemotherapy concepts in large cell lymphoma.
    Coleman M, Armitage JO, Gaynor M, McDermott D, Weisenburger DD, Adler K, Beshevkin M, Silver RT, Reisman AM, Pasmantier MW.
    Semin Hematol; 1988 Apr 01; 25(2 Suppl 2):23-33. PubMed ID: 2456620
    [Abstract] [Full Text] [Related]

  • 19. [Adriamycin for the treatment of non HOdgkin's lymphomas (author's transl)].
    Parlier Y, Gorin NC, Stachowiak J, Najman A, Duhamel G.
    Sem Hop; 1988 Apr 01; 57(41-42):1685-90. PubMed ID: 6272402
    [Abstract] [Full Text] [Related]

  • 20. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR, Zhang YJ, Xie FY, Zheng W, Li HX, Xia YF, Lin TY, Lu TX.
    Ai Zheng; 2006 Dec 01; 25(12):1543-9. PubMed ID: 17166383
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.